InvestorsHub Logo
Followers 321
Posts 23945
Boards Moderated 0
Alias Born 04/05/2011

Re: None

Sunday, 04/12/2020 10:27:54 PM

Sunday, April 12, 2020 10:27:54 PM

Post# of 198687
This all new??!

Enzolytics currently holds a 49% Interest in Immunotech Laboratories BG-Europe. Immunotech BG-Europe has a license for the development and commercialization of Enzolytics Patented ITV-1 Technology. Immunotech BG-Europe , under the branded ImmunH , utilizing the technology has successfully completed Phase III clinical trials at the Specialized Hospital for Active Treatment of Infectious and Parasite Disease in Sofia, Bulgaria, specific for the treatment of HIV/AIDS.



https://enzolytics.com/immunh-bg%2Feurope

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News